{"name":"Galena Biopharma, Inc.","slug":"galena-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Anagrelide CR","genericName":"Anagrelide CR","slug":"anagrelide-cr","indication":"Essential thrombocythemia","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"NeuVax™ vaccine","genericName":"NeuVax™ vaccine","slug":"neuvax-vaccine","indication":"HER2-positive breast cancer (adjuvant setting, Phase 3)","status":"phase_3"}]}],"pipeline":[{"name":"Anagrelide CR","genericName":"Anagrelide CR","slug":"anagrelide-cr","phase":"phase_2","mechanism":"Anagrelide CR works by inhibiting platelet aggregation and reducing platelet count.","indications":["Essential thrombocythemia"],"catalyst":""},{"name":"NeuVax™ vaccine","genericName":"NeuVax™ vaccine","slug":"neuvax-vaccine","phase":"phase_3","mechanism":"NeuVax is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing the HER2 protein.","indications":["HER2-positive breast cancer (adjuvant setting, Phase 3)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNVkhFa2IxZGFhMXh4bmlBalQ2UjN5Q0ZoR29kZ3lZQ0FUNGF2WlFNUGpUUzM2VTVtTlNXUDZrQ01LLU1rSFdmZlR1ZGFpSEw0aGtOU1JYTjNTZkdXR2dROEFRR1JLNE9RaTB3MVk1M0RGU0MzWG9mZk9BVXZGa1dXMkNjeVVNRG0xZ0pQMng2dUhvcFo1ZlpTblh0eEF6cGx3cGpOQWVZNVBZbTd6MHc?oc=5","date":"2026-02-27","type":"pipeline","source":"Benzinga","summary":"Why Are Shares Of Xeris Biopharma Falling Friday? - Benzinga","headline":"Why Are Shares Of Xeris Biopharma Falling Friday?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWXFpU1BMVGp6MlZ4VUYyXzdScDRQMnJHQUdVM2EtXzFmYTg3ZWdqYU9sQXlHb2d4TmZEQW83clRSRnF0SFU3aUQta3VaUW1vR3ViU0l2Z0JkZUlDWGdjaDhDeHFoRzQ0RFJaMURwTXNKbDU4SkFoV3puOUlhNUk4REszZ2Nlbzh3NjFFSnJOdWI3NU9rSTJYQnMtZHE2d3pnNW5wWXc4QldVZXMwZ1F5OTQxSHdIUzhSXzNwaUMzOEtNLW9HZ2FV?oc=5","date":"2021-06-07","type":"pipeline","source":"Reuters","summary":"Ex-CEO who became biotech consultant gets six months in prison for insider trading - Reuters","headline":"Ex-CEO who became biotech consultant gets six months in prison for insider trading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9NeGh6SmFITXpMa2htVUdndHRBSjZ3QW85ZXVydDQ4Ykw5V0Nqd0JNMmZENldCQ2JBRm1NTUpHRWQ0THppazVMX2hSSDVTN0pGMEdJTWJPYldlUlNoMGlLSUNsNmMtXzBVaXI4TVFJZ2J6UVVXcDhF?oc=5","date":"2019-02-15","type":"pipeline","source":"Worcester Business Journal","summary":"Phio Pharma CEO Cauwenbergh to retire - Worcester Business Journal","headline":"Phio Pharma CEO Cauwenbergh to retire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPSmFOUk5nUk5EZHZsTnM0dG4zTW5IWlhVZVY3aTdNaVRWSTRpUHVpejl4djhJdzlpTTZSOGVnTWNLWFluTzZybkRSVDBMOXBaYWtTUVB5WVRvMzZaOUdxczdvb1pTRDljSDNUcEF4dmpYVXV3dWJzb1hCYkdDVXF1REZ3NA?oc=5","date":"2018-06-27","type":"regulatory","source":"Medtruth","summary":"FDA Reveals Pharma Companies Blocking Cheaper Generic Medications - Medtruth","headline":"FDA Reveals Pharma Companies Blocking Cheaper Generic Medications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE15Y2FPRDZxb0pFNFVKMGM0bUt5Zk5PT0JPUFc2RFY3dmRoYXYxclN0NzVLaTV0cFA3dGcxVzl0VlpodUh6ckh6MERUU0lPMDZVdzl5OWlzMEZkNmozazR2YTB3?oc=5","date":"2018-05-18","type":"regulatory","source":"InvestorPlace","summary":"FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs - InvestorPlace","headline":"FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPNUR3R3R0Z0tGeVJoUV9sMndyRmdsc2owc1RGRmF6WFkyblFpNEJsbURpbVBTVWVWV3RGblNxMzR4U1RNWmtpbnhLaTFneXgwR01ucmwtZEkyWEZWRk1LSEhFSy1lWFBqVzNMTG5TNldEV0xvSld1WVZqdEFYam5rU1h0d0ZVQmF6TVE?oc=5","date":"2018-02-15","type":"pipeline","source":"Yahoo Finance","summary":"Company Update (NASDAQ:GALE): Galena Biopharma Inc Shares Are Racing Up the Market 17%; Here’s Why - Yahoo Finance","headline":"Company Update (NASDAQ:GALE): Galena Biopharma Inc Shares Are Racing Up the Market 17%; Here’s Why","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQcmVhREZIeElkTkVYbk80ME1VOGNXLURxd2h0ZmRtRDFnSW5NQWNOak9KbTlwZUlDSm5ob2laNUNMMHlPWFhQUVc3eldVTVVLOEptQk1NMmo5OXVyRUpzdmtwcVBMMjVQVEJDV292Z05faFZQNGVKXzJOdGZfZlk1SmpWYjRPUEFX?oc=5","date":"2017-08-09","type":"pipeline","source":"BioPharma Dive","summary":"Troubled Galena swallowed by Sellas - BioPharma Dive","headline":"Troubled Galena swallowed by Sellas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNWVUzZU5GV1VWTnh0R3BMUUQxRFBxOGFhczAwU1puWGNmc05qNXhoWklYWFdOS2pTSDJMNzJDcjRMX21uaUZQbTJGbGJlY2Q5YWU2enppcHIyM0Zac0Q0NndtMDE0TkpTMi1ORlNyQXlfNFJvLWRFak1SZlhsYWwtMHNJcEJESVJLczhjY0FUX3VBMVlIY0FWdDItR1FXeXNKWkExaFgwUnVobkVGNW5PRHRfMFdMZUNOUUZwUWRFdnV0ZEgwSi1uS2NkTjAxYjR6bEdleHpmcWJ6MHNiWmpESU5ITkhFNWhD?oc=5","date":"2017-08-08","type":"deal","source":"GlobeNewswire","summary":"Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group - GlobeNewswire","headline":"Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNVGRIellmNTRULXpqSHU1MFVmcVlUUFl2MjRILXJGZlZXOWFZbUJnQ0RjX09oV25zNHpEZEJpYk1hN3NZQUdwVkhzUFM5UVBFbkJvTFZzRU02RVpOWGYySG9FbzlmY3RwbF96ZF9OTzEwNGR3aU1LMWV4Wk00enZBN2lnUm83OVJGUlE5S2ZhOTNremRYYWc?oc=5","date":"2015-11-22","type":"deal","source":"Insider Monkey","summary":"Is Galena Biopharma Inc (GALE) A Good Stock To Buy? - Insider Monkey","headline":"Is Galena Biopharma Inc (GALE) A Good Stock To Buy?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOMmlHSmZjYlNJaUlpUnloVHRlVE9VeF95VlBGLW4yT2xVLTEyWWtzNnczbFVSSUJQTjBGamttZnBpUDJRaGllMUVNVWp2blNTV09sVlBUajJXcUhZbnVFaGJ0WFM3Y2hJMHdROUhmamVKMEJFdy04NWJLNG5IaFpMTzhxWW1EY2xsQlY2QUdxTVBDc0tPeDc2V0NHYVY2RXozdl9ZMmg1WmY0SmZKY1Zv?oc=5","date":"2014-08-21","type":"pipeline","source":"BioSpace","summary":"Galena Biopharma CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named - BioSpace","headline":"Galena Biopharma CEO Allegedly Fired Following Stock-Promotions Scandal, New CEO Named","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPc21HZXJaYXp1YnJySlB3UG5pd05YSUtYYzJ3dGFBWWJoZzZhdWNnYUZtdGdTcmtJY0hpSk1FZ201eEJjdlhKMTQtWGR5b2doLXpDR2dpMDFvMFZDTE1VSUJPVURxaDRvOXM4a201dUtxTHM4bkMtWWVtdk95c21XZk1IZm13d0JkY0RsOGZBak9HX0FzRU1CY2VBV0hzVzZoVDJn?oc=5","date":"2013-03-18","type":"pipeline","source":"Fierce Biotech","summary":"Abstral® by Orexo sells in the United States to Galena Biopharma, Inc. - Fierce Biotech","headline":"Abstral® by Orexo sells in the United States to Galena Biopharma, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPaUlzNVZCeFJ4V2lRc3YweTZDR2V0R19YT3pHVHBNOWtObHZhenMyRW1NbE1PbFB6NzI0ZUo1WnhyMFZqeXBwZUdIT0F1YWNlX055Sy10dENMdHdtdjRqbW5fSHRRTWhGY2Vadm5DeHdtWkNJX190cW1PRU0tUEN0RnBUUVBYLU9lTkdiOVdEZTBTX3R6VzZn?oc=5","date":"2012-07-08","type":"pipeline","source":"Worcester Telegram","summary":"Dr. Geert Cauwenbergh - Worcester Telegram","headline":"Dr. Geert Cauwenbergh","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}